GAD2 and aceruloplasminemia: Patients with Fisher’s syndrome (n = 10) and cerebellar ataxia associated with anti-GAD65 antibodies (n = 8) showed hypermetabolism in the cerebellum, which was also observed in 33 patients with NMDA-antibody encephalitis [120, 122, 123].